Biophoton Therapy for Brain Disorders

(Alzheimer Trial)

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: First Institute of All Medicines

Disqualifiers: Untreated mental illnesses, Ventilator, Implanted devices, Severe diabetes, others

Compensation: Varies

Number of Visits: 6

80 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment called biophoton therapy for brain disorders such as Alzheimer's, dementia, stroke, traumatic brain injury, and Parkinson's. The researchers aim to determine if this therapy can improve symptoms by using special devices placed under beds to emit healing light particles. Participants will receive either the active biophoton treatment or a placebo (inactive treatment) for comparison. Individuals with a clinical diagnosis of one of these brain disorders who can stay in a hotel and have a supportive caregiver may be suitable for this study. As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research in innovative therapies.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this biophoton therapy is safe for brain disorders?

Research has shown that biophoton therapy is safe for individuals with conditions such as Alzheimer's, dementia, stroke, traumatic brain injury, and Parkinson's disease. Earlier studies found that this therapy is generally well-tolerated and can be effective for these brain disorders. These studies reported no major side effects, suggesting that the treatment does not cause serious harm and might help improve symptoms. However, individual reactions can vary with any treatment. Consulting a healthcare provider is advisable to determine if this therapy is suitable. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about Biophoton Therapy for brain disorders because it represents a novel approach using biophotons, which are light particles believed to have healing properties. Unlike traditional treatments that often involve medications or invasive procedures, this therapy delivers biophotons through a non-invasive method—participants simply rest on a bed under which Biophoton Generators are placed. The unique mechanism of action, utilizing a biophoton field, offers a potential new avenue for treatment without the side effects typical of pharmaceuticals. This innovative approach could pave the way for safer, more natural interventions in managing brain disorders.

What evidence suggests that biophoton therapy is effective for brain disorders?

Earlier studies have shown that biophoton therapy holds promise for treating brain disorders such as Alzheimer's disease, dementia, stroke, traumatic brain injury, and Parkinson's disease. Research indicates that 75% of participants reported fewer Alzheimer's symptoms, 88% experienced a better quality of life, and 94% showed improved brain function. These findings suggest that biophoton therapy could effectively treat various brain conditions. In this trial, participants in the treatment group will receive biophoton therapy using active Biophoton Generators, while those in the control group will initially receive a placebo from inactive generators before switching to the active treatment. The therapy uses light particles to potentially heal and improve brain health. ^{1 6 7 8 9}

Are You a Good Fit for This Trial?

This trial is for adults with brain disorders like Alzheimer's, dementia, stroke, TBI, or Parkinson's. Participants need a caregiver to help them and must be able to give consent. They should speak English (or have translation) and women must test negative for pregnancy. People with untreated mental illnesses, reliance on ventilators, electronic implants in the brain or body, severe chronic diseases or life-threatening conditions can't join.

Inclusion Criteria

You need to speak English fluently, or your caregiver can translate for you.

I am over 18 and will be staying in a hotel.

I have a diagnosed brain disorder.

Exclusion Criteria

Pregnant women

Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert

Someone that relies on a ventilator

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Initial Treatment

Participants use either placebo or active Biophoton Generators for 2 weeks during sleep

2 weeks

Baseline visit, 2-week assessment

Extended Treatment

Participants in the placebo group switch to active treatment for 4 weeks; others continue treatment

4 weeks

4-week assessment

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Biophotonizer

Trial Overview The study tests a Biophoton Generator called 'Biophotonizer' at Tesla MedBed Center in Butler, PA. It aims to confirm its safety and effectiveness against various brain disorders through a randomized trial where patients are blindly assigned to receive either the therapy or placebo without knowing which one they get.

How Is the Trial Designed?

Group I: Treatment Group Experimental Treatment 1 Intervention

The 14 active Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for 4 weeks. Participants will receive biophotons inside of the biophoton field generated by 14 active Biophoton Generators

Group II: Control Group Placebo Group 1 Intervention

The 14 inactive Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for the first 2 weeks. Then will be switched to the active treatment group for being treated for 4 weeks. Participants will receive placebo effect from the 14 inactive comparators.

Who Is Running the Clinical Trial?

First Institute of All Medicines

Lead Sponsor

Trials

4

Recruited

220+

Citations

1. clinicaltrials.gov clinicaltrials.gov/study/NCT06147999

Impact of a Biophoton Therapy on Patients With Brain ... Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, ...

2. centerwatch.com centerwatch.com/clinical-trials/listings/NCT06147999/impact-of-a-biophoton-therapy-on-patients-with-brain-disorders

Impact of a Biophoton Therapy on Patients With Brain ... The newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or ...

3. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC11464434/

Editorial: Photobiomodulation therapy for brain disorders By measuring outcomes such as cognitive function and caregiver burden, this protocol will provide critical data on the potential therapeutic ...

4. onlinescientificresearch.com onlinescientificresearch.com/articles/noninvasive-biophoton-therapy-for-neurocognitive-and-physical-recovery-in-retired-athletes-with-traumatic-brain-injury-a-pilot-stu.pdf

Non-Invasive Biophoton Therapy for Neurocognitive and ... Introduction. Traumatic brain injury (TBI) remains one of the most complex and debilitating conditions affecting retired professional athletes,.

5. researchgate.net researchgate.net/publication/387855271_Clinical_Success_of_Biophoton_Therapy_in_Improving_Cognition_of_Alzheimer's_Disease

Clinical Success of Biophoton Therapy in Improving ... Seventy‐five percent (75%) participants reduced the Alzheimer's Questionnaire severity; 88% increased life quality SF‐36 score; and 94% increased brain ...

6. fda.gov fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tesla-biohealing-inc-658010-08102023

Tesla BioHealing, Inc. - 658010 - 08/10/2023 “Moderate Conditions Lyme Disease, COPD, Localized Injury, Back Pain, Alzheimer's/Dementia, Epilepsy/Seizure Disorders, Erectile Dysfunction ...

7. trials.arthritis.org trials.arthritis.org/trials/NCT06915012

Impact of Biophoton Therapy on Chronic Severe Arthritis Pain Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can ...

8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC9366035/

The effect of photobiomodulation on the brain during ... Recent studies have shown that when applied during the state of sleep, photobiomodulation can also be of benefit, but in a different way.

9. onlinescientificresearch.com onlinescientificresearch.com/articles/twelveday-live-blood-analysis-reveals-hemorheological-and-microvascular-restoration-in-a-parkinsons-disease-patient-following-biop.pdf

Twelve-Day Live Blood Analysis Reveals Hemorheological ... Safety and Efficacy of Biophoton Quantum Medicine in. Treating Neurodegenerative Diseases. Journal of Neurology. Research Reviews & Reports 7: 1-6. 8. Van ...